SCHEMBL31682201

SCHEMBL31682201

CCNCc1ccc(-c2ccccc2-c2cccc3c2CN(C)C3=O)o1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AMY1A P0DUB6 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ FTO Q9C0B1 3/20 0.35
▸ HTR6 P50406 2/20 0.33
▸ PDCD1 Q15116 1/20 0.33
▸ CD274 Q9NZQ7 1/20 0.33
▸ TP53 P04637 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ BRCA1 P38398 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ UGCG Q16739 1/20 0.32
▸ GAA P10253 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ ALKBH5 Q6P6C2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ HRH1 P35367 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31682173 0.91 AMY1A (0.39) AMY1AL3MBTL1FTOHTR6PDCD1
SCHEMBL31682190 0.89 LDHA (0.40) AMY1AL3MBTL1FTOHTR6ALDH1A1
SCHEMBL31682193 0.88 SOS1 (0.40) AMY1AL3MBTL1FTOPDCD1CD274
SCHEMBL31682178 0.88 UGCG (0.34) AMY1AL3MBTL1FTOHTR6PDCD1
SCHEMBL31682181 0.86 AMY1A (0.37) AMY1AL3MBTL1FTOHTR6PDCD1
SCHEMBL31682174 0.85 HRH1 (0.48) AMY1AL3MBTL1FTOHTR6TP53
SCHEMBL31682179 0.84 ALDH1A1 (0.37) AMY1AFTOHTR6PDCD1CD274
SCHEMBL31682198 0.84 USP2 (0.36) PDCD1CD274USP2KMT2AGAA
SCHEMBL31682194 0.83 ALDH1A1 (0.37) L3MBTL1MEN1KMT2AUGCGGAA
SCHEMBL31682177 0.83 UGCG (0.34) MEN1KMT2AUGCGMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250289808-A1 NOVEL CARBOXAMIDE REDOX DERIVATIVE OF INHIBITING BET PROTEIN AND COMPOSITION FOR PREVENTING AND TREATING OPHTHALMIC DISEASES USING THE SAME BenoBio Co., Ltd (KR) 2025-09-18 — — US disclosed
EP-4613329-A1 COMPOUND FOR INHIBITING BRD PROTEIN Benobio Co., Ltd. (KR) 2025-09-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250289808-A1 NOVEL CARBOXAMIDE REDOX DERIVATIVE OF INHIBITING BET PROTEIN AND COMPOSITION FOR PREVENTING AND TREATING OPHTHALMIC DISEASES USING THE SAME BET1, BRD4, BRD3 AMY1A 3698/4885L3MBTL1 3879/4885FTO 3244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback